Skip to content

Efficacy of hypertonic dextrose prolotherapy in the treatment of temporomandibular dysfunction

Efficacy of hypertonic dextrose prolotherapy in the treatment of temporomandibular dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006158
Enrollment
Unknown
Registered
2015-03-27
Start date
2015-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular dysfunction

Interventions

Two groups:1 ml 20% dextrose with 0.2% lidocaine versus 1 ml of normal saline with 0.2 % lidocaine, 13 weeks

Sponsors

Dr Regina Wing Shan SIT
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: -adults >=18 years old who complain of pain in the face for more than 6 months and have at least one of the following symptoms referable to the jaw: difficulty chewing, stiffness in the jaw, tension in the jaw ? fatigue with eating or grinding of teeth; -All the recruited participants should have their average numerical rating scale (NRS) > 5 for both facial pain and jaw dysfunction in the past 6 months.

Exclusion criteria

Exclusion criteria: - Prior TMJ prolotherapy; - AnyTMJ injections within 3 months; - Co-morbidity severe enough to prevent participation in the study protocol like attendance at scheduled injection appointments; - Unable to understand or to give consent.

Design outcomes

Secondary

MeasureTime frame
The secondary outcome will be the change in maximal mouth opening (MMO) in centimeter and “end feel” of the TMJ (hard or soft).;

Primary

MeasureTime frame
Nurmerical rating scale (NRS) in the face and the NRS for jaw dysfunction at week 1, week 13 and at 1 year.;

Countries

China

Contacts

Public ContactDr Regina Wing Shan SIT
reginasit@cuhk.edu.hk+852 25039053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026